Le Lézard
Classified in: Health
Subjects: PDT, SCZ

New Book Gives Advice on Providing Support to Widows and Widowers


WINTER GARDEN, Fla., April 17, 2020 /PRNewswire-PRWeb/ -- Author Cynthia Mascarenhas shares practical advice for those seeking to show their support for a widow or someone caring for a terminally ill spouse in Walk with a Widow. Empower. Educate. Prepare: A Guide to Launching the Walk with a Widow Program ($13.99, paperback, 9781630507336; $6.99, e-book, 9781630507343).

After witnessing such a horrific loss, it is difficult for family and friends to know how to help a loved one whose spouse has passed away. Speaking from experience as a widow herself, Mascarenhas walks those who are willing through a checklist of do's and don'ts, as well as financial and other practical matters that need to be dealt with.

"My own personal journey as a widow revealed to me that the church, family, and friends are ill-equipped for the task of showing support for a widow. They may want to make a difference but do not know how. This book was written as a practical tool offering solutions to some very basic challenges a person encounters in dealing with a widow," said Mascarenhas.

Cynthia Mascarenhas is a Registered Nurse and Independent Legal Nurse Consultant. She has served as a member of the Board of Directors of the Greater Orlando Chapter of Legal Nurse Consultants and on various committees for the American Association of Legal Nurse Consultants. Mascarenhas was widowed on February 4th, 2018 when she lost her husband of 29 years, Franz Mascarenhas, to a sudden heart attack.

###

Xulon Press, a division of Salem Media Group, is the world's largest Christian self-publisher, with more than 15,000 titles published to date. Walk with a Widow Empower. Educate. Prepare is available for purchase as a bundle that includes additional training resources Please contact 321-276-9590 or [email protected] to place an order.

 

SOURCE Xulon Press


These press releases may also interest you

at 07:10
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced financial results and clinical updates for the twelve months ended...

at 07:10
Kelonia Therapeutics, a biotech company revolutionizing in vivo gene delivery, today announced the appointments of global leaders in cell therapy and drug development, Kristen Hege, M.D., and Mathai Mammen, M.D., Ph.D., to its board of directors....

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the clinical development plan intended to enable...

at 07:05
Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate (ADC) therapies for the treatment of a wide range of cancers, announced that George Eliades, Ph.D., has joined the...

at 07:05
Seres Therapeutics, Inc. ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on March 25, 2024, the Compensation and Talent Committee of Seres' board of directors granted inducement equity grants covering an...

at 07:05
Gilead Sciences, Inc. and Xilio Therapeutics, Inc. today announced an exclusive license agreement to develop and commercialize Xilio's Phase 1 tumor-activated IL-12 program, XTX301. Xilio Therapeutics is a clinical-stage biotechnology company...



News published on and distributed by: